Silk-Hyaluronic Acid Based Tissue Fillers and Methods of Using the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 16/626,081, filed Dec 23, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,660,372 | Silk-Hyaluronic Acid Based Tissue Fillers and Methods of Using the Same In force · High confidence UsedRemaining | Evolved by Nature, Inc. | In force | High confidence | ||
| US 12,611,484 | Silk-Hyaluronic Acid Based Tissue Fillers and Methods of Using the Same In force · Low confidence | Evolved by Nature, Inc. | In force | Low confidence | ||
| Application 16/626,081 | Silk-Hyaluronic Acid Based Tissue Filers and Methods of Using the Same Pending Not granted | Evolved by Nature, Inc. | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Evolved by Nature, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.